Sally Sue System Platform With Instrument

Added: Nov 16, 2016 11:22 am The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) in support of the Vaccine Research Center (VRC) intends to negotiate on an other than full and open competition for imaging equipment with Proteinsimple, 3001 Orchard Parkway, San Jose, CA 95134. This equipment includes a Sally Sue System-Capillary based nanoimmunoassay size-based separation platform with instrument, computer, Windows OS, Compass software (10-seat license), & one year warranty and associated installation and maintenance service. Proteinsimple is the original equipment manufacturer (OEM). All responsible sources who are certified by Protein Simple as authorized third party resellers may submit a proposal. The vendors shall provide certification from OEM that they are an authorized reseller provider for this equipment. All responsible sources may submit a response that will be considered. A firm fixed price award will be made in accordance with the statutory authority for this sole source requirement 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one source available, no substitutions possible. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Offers must be submitted no later than 5:00 P.M. Eastern Standard Time, Wednesday, November 30, 2016 to akilah.bullock@nih.gov.